The D.C. Lung Cancer Conference 2026, organized by MedStar Health, will take place on 10 October 2026, from 7:00 AM to 9:00 PM, at the JW Marriott in Washington, D.C.

The one-day multidisciplinary meeting will provide clinicians with a comprehensive update on recent advances across the lung cancer care continuum, from screening and diagnosis to molecular testing and treatment.

Topics will include CT screening, liquid biopsy, interpretation of biomarker testing, smoking cessation, minimally invasive surgery, neoadjuvant and adjuvant systemic therapy, immunotherapy, targeted therapies for molecularly defined NSCLC, advanced small cell lung cancer, immune-mediated toxicities, and rarer thoracic malignancies including thymic tumors and mesothelioma.

Sessions will feature international experts, detailed case discussions, frequent Q&A, and an opening perspective from a patient advocate. The conference offers up to 7.0 continuing education credits, and proceeds from the meeting will benefit the Lung Cancer Care Research Fund. Registration is $250 for physicians, $195 for IASLC members, free for residents/fellows, $175 for several allied healthcare professional categories, and $350 for industry professionals.